MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $4.45 Million Stock Position in Humana Inc. $HUM

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Humana Inc. (NYSE:HUM) by 1.8% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 16,810 shares of the insurance provider’s stock after purchasing an additional 299 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Humana were worth $4,448,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in HUM. Cary Street Partners Investment Advisory LLC lifted its stake in Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after buying an additional 46 shares during the period. Riverview Trust Co acquired a new position in Humana in the first quarter valued at approximately $34,000. Garde Capital Inc. acquired a new position in Humana in the first quarter valued at approximately $36,000. Zions Bancorporation National Association UT acquired a new position in Humana in the first quarter valued at approximately $37,000. Finally, Whipplewood Advisors LLC lifted its stake in Humana by 639.1% in the first quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider’s stock valued at $45,000 after buying an additional 147 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Trading Up 2.0%

NYSE HUM opened at $279.04 on Friday. The firm has a market capitalization of $33.56 billion, a P/E ratio of 21.42, a PEG ratio of 1.61 and a beta of 0.44. The business has a fifty day simple moving average of $264.58 and a 200 day simple moving average of $257.07. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $331.00. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). The business had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter last year, the company earned $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. On average, analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. Humana’s dividend payout ratio is presently 27.17%.

Analyst Ratings Changes

Several brokerages have issued reports on HUM. Wells Fargo & Company dropped their price target on Humana from $348.00 to $344.00 and set an “overweight” rating on the stock in a research note on Thursday, August 14th. Bank of America boosted their price target on Humana from $285.00 to $312.00 and gave the company a “neutral” rating in a research note on Tuesday, September 2nd. Piper Sandler dropped their price target on Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a research note on Thursday, July 31st. Truist Financial lowered their target price on Humana from $280.00 to $260.00 and set a “hold” rating on the stock in a research report on Wednesday, July 16th. Finally, Robert W. Baird lowered their target price on Humana from $300.00 to $297.00 and set a “neutral” rating on the stock in a research report on Friday, July 25th. Seven analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $289.24.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.